top of page
Executive Spotlights

ADARx Pharmaceuticals Secures $200M Series C Financing, Paving Path for Next-Gen RNA Therapeutics

San Diego, CA, August 9, 2023 (Business Wire) -- ADARx Pharmaceuticals, Inc., a clinical-stage biotech enterprise spearheading the advancement of next-generation RNA therapeutics, has announced the successful conclusion of a $200 million Series C funding round. This funding endeavor was jointly spearheaded by Bain Capital Life Sciences and TCGX, and further embraced by new investors including Blackrock, Commodore Capital, Cormorant Asset Management, HBM Healthcare Investments, Invus, Marshall Wace, Redmile Group, T. Rowe Price Associates Inc., Venrock Healthcare Capital Partners, and Vivo Capital.

Read full article here.

Recent Posts

See All

AxoSim appoints Alif Saleh as CEO

New Orleans, LA, June 14, 2024 (Indian Pharma Post) -- AxoSim, a life science firm specializing in lab-grown human brains, has appointed Alif Saleh as its new CEO. Salef, a company builder, brings e


Life Science Headlines
bottom of page